As of 2025-07-09, the Relative Valuation of Krebs Biochemicals and Industries Ltd (KREBSBIO.NS) is (215.85) INR. This relative valuation is based on P/E multiples. With the latest stock price at 86.00 INR, the upside of Krebs Biochemicals and Industries Ltd based on Relative Valuation is -351.0%.
The range of the Relative Valuation is (164.68) - (232.91) INR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 28.5x | 19.8x |
| Forward P/E multiples | 12.8x - 18.6x | 14.7x |
| Fair Price | (164.68) - (232.91) | (215.85) |
| Upside | -291.5% - -370.8% | -351.0% |
| Date | P/E |
| 2025-07-08 | -6.88 |
| 2025-07-07 | -6.88 |
| 2025-07-04 | -7.00 |
| 2025-07-03 | -6.81 |
| 2025-07-02 | -7.04 |
| 2025-07-01 | -7.04 |
| 2025-06-30 | -7.11 |
| 2025-06-27 | -7.15 |
| 2025-06-26 | -6.94 |
| 2025-06-25 | -6.89 |
| 2025-06-24 | -7.10 |
| 2025-06-23 | -7.19 |
| 2025-06-20 | -7.12 |
| 2025-06-19 | -7.04 |
| 2025-06-18 | -7.20 |
| 2025-06-17 | -7.40 |
| 2025-06-16 | -7.59 |
| 2025-06-13 | -7.03 |
| 2025-06-12 | -7.21 |
| 2025-06-11 | -7.52 |
| 2025-06-10 | -7.56 |
| 2025-06-09 | -8.32 |
| 2025-06-06 | -7.77 |
| 2025-06-05 | -6.55 |
| 2025-06-04 | -6.20 |
| 2025-06-03 | -6.07 |
| 2025-06-02 | -5.98 |
| 2025-05-30 | -6.00 |
| 2025-05-29 | -6.12 |
| 2025-05-28 | -5.94 |
| 2025-05-27 | -5.96 |
| 2025-05-26 | -5.92 |
| 2025-05-23 | -6.07 |
| 2025-05-22 | -5.92 |
| 2025-05-21 | -6.03 |
| 2025-05-20 | -6.00 |
| 2025-05-19 | -6.08 |
| 2025-05-16 | -6.14 |
| 2025-05-15 | -6.05 |
| 2025-05-14 | -5.93 |
| 2025-05-13 | -6.07 |
| 2025-05-12 | -6.00 |
| 2025-05-09 | -5.83 |
| 2025-05-08 | -5.84 |
| 2025-05-07 | -5.98 |
| 2025-05-06 | -5.80 |
| 2025-05-05 | -6.20 |
| 2025-05-02 | -6.12 |
| 2025-04-30 | -5.93 |
| 2025-04-29 | -5.87 |